PTAB issues key decision over revolutionary CRISPR technology, but this tale is not over yet – IAM (registration) (blog)
Forbes |
PTAB issues key decision over revolutionary CRISPR technology, but this tale is not over yet
IAM (registration) (blog) The gene-editing tool CRISPR is in the process of transforming the life sciences industry. Perhaps not surprisingly with such a revolutionary technology still in its relative infancy, a dispute over patents between universities and research institutes … How Much Is a CRISPR Patent License Worth? – Forbes Controversial CRISPR Can Alter And Wipe Out Malaria Broad Institute Wins CRISPR Patent Decision |
